(2-Chloro-4-(trifluoromethoxy)phenyl)boronic acid, 95.0%, 250mg

3-Chloro-2-fluoroisonicotinic acid, 95.0%, 1g

N-(2-chloroethyl)-4-methylbenzenesulfonamide, 5g

3-(2-bromoethyl)tetrahydrothiophene 1,1-dioxide, 95.0%, 1g

2-Amino-4-(tert-butyl)phenol, 95.0%, 500g

6-METHYLDIBENZO[B,F]OXEPIN-10(11H)-ONE, 95.0%, 1g

5,6-Dibromo-1H-indole-3-carboxylic acid, 97%, 5g

N-(2,3-dichlorophenyl)acetimidamide, 98%, 1g

(5-Fluoro-1H-benzo[d]imidazol-2-yl)methanol, 95.0%, 5g

3-(Pyrimidin-2-yl)-1,2,4-thiadiazol-5-amine, 95+%, 1g

Columna HPLC NUCLEODUR® C18 Gravedad 5 µm, 250 mm, 4 mm, 1 Pieza(s)

(2r)-3,3-Difluoro-2-methyl-azetidine;hydrochloride, 98%, 500mg

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)dibenzofuran>99.0%(GC)(T)5g